Skip to content

Developing low-cost house floors to control sand flea disease (jiggers) in Kenya

Developing low-cost house floors to control Tungiasis in Kenya

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN62801024
Enrollment
36
Registered
2023-07-07
Start date
2019-10-09
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevention of tungiasis among children under 18 years Infections and Infestations

Interventions

A low-cost floor retro-fitted into 12 houses of families with at least two cases of tungiasis. A second intervention group of 12 houses received a local standard concrete floor and the control group r

Sponsors

International Centre of Insect Physiology and Ecology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Households with at least two children infected with tungiasis and having at least 5 embedded fleas each 2. House with an unsealed floor 3. Houses with a maximum floor area of 36m² 4. Head of household willing and able to move out of the house while the floor is installed and provide informed consent

Exclusion criteria

Exclusion criteria: 1. Households with a concrete sealed floor 2. Houses larger than 36m² 3. Household not willing or able to move out of the house while the floor is installed

Design outcomes

Primary

MeasureTime frame
Proportion of participating children with live fleas embedded in their feet as detected by eye at midline (4 months) and endline (10 months).

Secondary

MeasureTime frame
1. Infection intensity of infected children measured by counting the number of all embedded fleas in both feet of participants at midline (4 months) and endline (10 months). 2. Acute symptom scores of infected children measured by counting the number of zones (9 in each foot) exhibiting each symptom (thermographic hotspot, desquamtation, fissures, ulcers, abscess) at midline (4 months) and endline (10 months).

Countries

Kenya

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026